[Treatment of extrahepatic manifestations associated with hepatitis C virus infection]

Gastroenterol Clin Biol. 2002 Apr:26 Spec No 2:B210-9.
[Article in French]
No abstract available

Publication types

  • Comparative Study
  • Consensus Development Conference
  • Review

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Autoantibodies / immunology
  • Cryoglobulinemia / etiology
  • Cryoglobulinemia / therapy
  • Drug Therapy, Combination
  • Fatigue / etiology
  • Female
  • Glomerulonephritis, Membranoproliferative / etiology
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy
  • Hepatitis C / immunology
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / immunology
  • Humans
  • Interferons / administration & dosage
  • Interferons / adverse effects
  • Lymphoproliferative Disorders / etiology
  • Male
  • Middle Aged
  • Odds Ratio
  • Porphyria Cutanea Tarda / etiology
  • Porphyria Cutanea Tarda / therapy
  • Pruritus / etiology
  • Ribavirin / administration & dosage
  • Ribavirin / adverse effects
  • Sjogren's Syndrome / etiology
  • Sjogren's Syndrome / therapy
  • Surveys and Questionnaires
  • Thrombocytopenia / etiology
  • Thrombocytopenia / therapy
  • Time Factors
  • Vascular Diseases / etiology
  • Vascular Diseases / therapy

Substances

  • Antiviral Agents
  • Autoantibodies
  • Ribavirin
  • Interferons